CAR T-Cell Win Streak Stopped by Negative Trial in Aggressiv

Patients, trial design, logistics among possible explanations for lack of EFS benefit

Related Keywords

Florida , United States , Tampa , American , Michaelr Bishop , Danl Longo , Charles Bankhead , Frederickl Locke , Wyndhamh Wilson , Mark Roschewski , American Society Of Hematology , University Of Chicago , Moffitt Cancer Center , American Society , New England Journal , Lymphoid Malignancies Branch , National Cancer Institute , Medpage Today ,